233 related articles for article (PubMed ID: 32601923)
1. A contemporary review on pathogenesis and immunity of COVID-19 infection.
Mirzaei R; Karampoor S; Sholeh M; Moradi P; Ranjbar R; Ghasemi F
Mol Biol Rep; 2020 Jul; 47(7):5365-5376. PubMed ID: 32601923
[TBL] [Abstract][Full Text] [Related]
2. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.
Singh KK; Chaubey G; Chen JY; Suravajhala P
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C258-C267. PubMed ID: 32510973
[TBL] [Abstract][Full Text] [Related]
3. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
[TBL] [Abstract][Full Text] [Related]
4. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
[TBL] [Abstract][Full Text] [Related]
5. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
6. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
[TBL] [Abstract][Full Text] [Related]
7. Genomic Epidemiology and its importance in the study of the COVID-19 pandemic.
Rodriguez-Morales AJ; Balbin-Ramon GJ; Rabaan AA; Sah R; Dhama K; Paniz-Mondolfi A; Pagliano P; Esposito S
Infez Med; 2020 Ahead of print Jun 1; 28(2):139-142. PubMed ID: 32275255
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
Bergmann CC; Silverman RH
Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
[No Abstract] [Full Text] [Related]
9. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
[TBL] [Abstract][Full Text] [Related]
10. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies mediate virus-immune pathology of COVID-19.
Jacobs JJL
Med Hypotheses; 2020 Oct; 143():109884. PubMed ID: 32512289
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.
Bartoszewski R; Dabrowski M; Jakiela B; Matalon S; Harrod KS; Sanak M; Collawn JF
Am J Physiol Lung Cell Mol Physiol; 2020 Sep; 319(3):L444-L455. PubMed ID: 32755307
[TBL] [Abstract][Full Text] [Related]
13. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
14. COVID-19 infection: the perspectives on immune responses.
Shi Y; Wang Y; Shao C; Huang J; Gan J; Huang X; Bucci E; Piacentini M; Ippolito G; Melino G
Cell Death Differ; 2020 May; 27(5):1451-1454. PubMed ID: 32205856
[No Abstract] [Full Text] [Related]
15. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
[TBL] [Abstract][Full Text] [Related]
16. Activation and evasion of type I interferon responses by SARS-CoV-2.
Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.
Afsar CU; Afsar S
J Reprod Immunol; 2020 Sep; 141():103154. PubMed ID: 32521376
[No Abstract] [Full Text] [Related]
18. Early Insights into Immune Responses during COVID-19.
St John AL; Rathore APS
J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
[TBL] [Abstract][Full Text] [Related]
19. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Drak Alsibai K
Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
[TBL] [Abstract][Full Text] [Related]
20. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Blanco-Melo D; Nilsson-Payant BE; Liu WC; Uhl S; Hoagland D; Møller R; Jordan TX; Oishi K; Panis M; Sachs D; Wang TT; Schwartz RE; Lim JK; Albrecht RA; tenOever BR
Cell; 2020 May; 181(5):1036-1045.e9. PubMed ID: 32416070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
